Your browser doesn't support javascript.
loading
Risk Factors of Multiple Myeloma Complicated with Venous Thromboembolism / 中国实验血液学杂志
Journal of Experimental Hematology ; (6): 1100-1107, 2023.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-1009967
Biblioteca responsável: WPRO
ABSTRACT
OBJECTIVE@#To analyze the clinical characteristics of venous thromboembolism (VTE) in patients with multiple myeloma (MM) and to identify the risk factors of VTE in MM patients.@*METHODS@#179 newly diagnosed MM (NDMM) patients admitted to The Second Hospital of Shanxi Medical University from January 2014 to December 2020 who were followed up for more than 6 months were collected, and they were divided into VTE group and control group according to whether combined with VTE. The clinical and laboratory data were compared between the two groups. Mann-whitney U test was used for inter-group comparison of measurement data, Chi-square test or Fisher's exact test was used for inter-group comparison of count data, and multivariate logistic regression analysis was performed to explore the risk factors of VTE in MM patients.@*RESULTS@#Compared with control group, the serum albumin (ALB) level in VTE group was significantly lower (P =0.033), the fibrinogen (FIB) level was significantly higher (P =0.016), and the proportion of patients with D-dimer≥2 000 ng/ml was significantly higher than that in the control group (26.3% vs 4.4%, P =0.002). There was a significant difference in M-component type between the two groups (P =0.028), and the proportion of IgG type in VTE group was higher. There were no statistically significant differences between two groups in age, sex, body mass index (BMI), the proportions of patients with hypertension, diabetes, coronary heart disease and cerebral infarction, white blood cell (WBC) count, platelet (PLT) count, liver and kidney function, plasma cells ratio in bone marrow, serum globulin (GLO), lactate dehydrogenase (LDH), β2-microglobulin (β2-MG) level, C-reactive protein (CRP) level, erythrocyte sedimentation rate (ESR), prothrombin time (PT), activated partial thromboplastin time (APTT), disease stage, thrombosis prevention and the use of immunomodulators (P >0.05). Multivariate logistic regression analysis showed that FIB level (OR=1.578, 95%CI1.035-2.407, P =0.034), D-dimer≥2 000 ng/ml (OR=5.467, 95%CI1.265-23.621, P =0.023) and IgG type (OR=4.780, 95%CI 1.221-18.712, P =0.025) were independent risk factors for VTE in MM patients.@*CONCLUSION@#MM patients are prone to VTE, and FIB level, D-dimer≥2 000 ng/ ml and IgG type are independent risk factors for VTE in MM patients.
Assuntos

Texto completo: Disponível Base de dados: WPRIM (Pacífico Ocidental) Assunto principal: Imunoglobulina G / Estudos Retrospectivos / Fatores de Risco / Tromboembolia Venosa / Mieloma Múltiplo / Anticoagulantes Limite: Humanos Idioma: Chinês Revista: Journal of Experimental Hematology Ano de publicação: 2023 Tipo de documento: Artigo
Texto completo: Disponível Base de dados: WPRIM (Pacífico Ocidental) Assunto principal: Imunoglobulina G / Estudos Retrospectivos / Fatores de Risco / Tromboembolia Venosa / Mieloma Múltiplo / Anticoagulantes Limite: Humanos Idioma: Chinês Revista: Journal of Experimental Hematology Ano de publicação: 2023 Tipo de documento: Artigo
...